TrialNeurology2017
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS.
Richard A Nash et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
75 papers cite itlatest 60 shown
this paperpooled ittrialcites it